INTRODUCTION {#S3}
============

Congenital generalized lipodystrophy (CGL; also known as Berardinelli-Seip congenital lipodystrophy \[BSCL\]) is an autosomal recessive disorder characterized by a near total loss of adipose tissue, severe hypertriglyceridemia, insulin resistance, and fatty liver ([@R1]; [@R25]). To date, four genes have been linked to CGL/BSCL: 1-acylglycerol-3-phosphate-O-acyltransferase-2 (*AGPAT2*)/CGL1, *SEIPIN*/CGL2, *CAVEOLIN-1*/CGL3, and *CAVIN-1*/CGL4 ([@R14]). The most severe form of human CGL/BSCL is caused by loss-of-function mutations in *SEIPIN*/*BSCL2*, which encodes an integral membrane protein of the endoplasmic reticulum (ER) with no recognizable functional domains ([@R14]; [@R6]; [@R24]). *Seipin* knockout (*Bscl2*^−/−^) mice have severe lipodystrophy and insulin resistance ([@R12]; [@R9]; [@R31]), demonstrating an essential role for *Seipin* in adipogenesis. SEIPIN and its non-mammalian orthologs also control the expansion of lipid droplets (LDs). The most prominent feature of *Seipin*-deficient cells is the formation of "supersized" LDs ([@R13], [@R15]; [@R42]; [@R44]; [@R20]; [@R22]). Thus, SEIPIN has a unique role in regulating both systemic (adipogenesis) and cellular (LD expansion) lipid storage.

Recent studies implicate SEIPIN and its yeast ortholog, Fld1 (also known as Sei1), in regulating phospholipid metabolism such that the amount of phosphatidic acid (PA) is increased in SEIPIN-deficient cells and tissues ([@R16]; [@R38]; [@R20]; [@R48]; [@R19]). We have postulated that in preadipocytes, increased PA acts as a peroxisome proliferator-activated receptor gamma (PPARγ) antagonist and thus blocks adipogenesis ([@R41]; [@R14]). In non-preadipocytes and yeast, PA promotes LD expansion, likely because it is fusogenic ([@R16]). However, exactly how the ER-localized SEIPIN might regulate the metabolism of phospholipids and PA remains unknown.

Through affinity isolation and tandem mass spectrometry analyses, we identified proteins that specifically co-precipitate with Fld1-GFP in the yeast *Saccharomyces cerevisiae*. The most prominent of these proteins was Gat1, a glycerol-3-phosphate acyltransferase (GPAT). As the rate-limiting step in the synthesis of triacylglycerol and glycerophospholipids, GPAT catalyzes the esterification of glycerol-3-phosphate with a long-chain acyl-coenzyme A (acetyl-CoA) to initiate the formation of PA ([@R4]; [@R26]; [@R46]). We found that mammalian SEIPIN specifically interacted with the corresponding mammalian GPAT orthologs, GPAT3 and GPAT4. SEIPIN deficiency in yeast, mammalian cells, and mouse tissues resulted in increased GPAT activity and changes in GPAT kinetics. These data strongly suggest that SEIPIN is an evolutionarily conserved regulator of GPAT and that targeting GPAT may have therapeutic potential in treating BSCL2.

RESULTS {#S4}
=======

Fld1 and Gat1 Physically Interact {#S5}
---------------------------------

To identify potential Fld1/SEIPIN-interacting proteins, we used the native promoter of *FLD1* on a low-copy plasmid in wild-type or *fld1*Δ yeast cells to express GFP alone or a functional Fld1-GFP fusion protein ([@R13]). Cell membranes were isolated and solubilized using three different buffer conditions, followed by affinity purification and tandem mass spectrometry analyses (see Experimental Procedures).

In all three buffer/lysis conditions used, 19 proteins co-precipitated with Fld1-GFP, but not with matrix or GFP alone ([Figure S1A](#SD1){ref-type="supplementary-material"}; [Table S1](#SD1){ref-type="supplementary-material"}). Because our previous studies strongly suggested that Fld1/SEIPIN regulates cellular PA content ([@R16]; [@R44]; [@R20]), we focused on the yeast GPAT, Gat1, which catalyzes the rate-limiting step in the de novo synthesis PA and all glycerolipids. Tagged and overexpressed Fld1 and Gat1 were co-immunoprecipitated from yeast ([Figure 1A](#F1){ref-type="fig"}), and this interaction was retained when both proteins were expressed at close to endogenous levels by adding tags at the C termini of their respective genomic loci ([Figure 1B](#F1){ref-type="fig"}). As recently reported ([@R45]), we also identified Ldb16 as an Fld1-interacting protein in our screen ([Figure S1A](#SD1){ref-type="supplementary-material"}; [Table S1](#SD1){ref-type="supplementary-material"}), and endogenous Ldb16 co-immunoprecipitated with both Fld1-FLAG ([Figure 1B](#F1){ref-type="fig"}) and Gat1 ([Figure 1C](#F1){ref-type="fig"}). Furthermore, Fld1 and Ldb16 also co-immunoprecipitated with Gat2, a second yeast GPAT that shares \~38% sequence identity and \~58% sequence similarity with Gat1 ([Figures 1C](#F1){ref-type="fig"} and [S1B](#SD1){ref-type="supplementary-material"}). However, a yeast AGPAT homolog, Slc4, did not co-immunoprecipitate with Fld1 as well as Gat1/2 ([Figure 1C](#F1){ref-type="fig"}). Fld1-Gat1/2 interaction was not affected in *ldb16* null cells ([Figure 1C](#F1){ref-type="fig"}), but we were not able to test whether the Ldb16 and Gat1/2 interaction requires Fld1, because Ldb16 is extremely unstable in the absence of Fld1 ([@R45]; data not shown).

Mammalian SEIPIN and GPAT3/4 Physically Interact {#S6}
------------------------------------------------

Mammals express four GPAT isoforms; GPAT1 and GPAT2 are present on the outer mitochondrial membrane, and GPAT3 and GPAT4 are present on the ER ([@R10]). GPAT1 is resistant to N-ethylmaleimide (NEM), whereas the other GPATs are sensitive to NEM. SEIPIN co-immunoprecipitated with both GPAT3 and GPAT4 in 3T3L1 preadipocytes ([Figure 2A](#F2){ref-type="fig"}). The interaction was significantly weakened (by \~50%) between GPAT3/4 and the SEIPIN missense mutant (T78A) that causes a human lipodystrophy ([@R39]) ([Figures 2B and 2C](#F2){ref-type="fig"}, lane 3; [Figures S1D and S1E](#SD1){ref-type="supplementary-material"}). The C-terminal cytoplasmic region of SEIPIN was not essential for the interaction with GPAT3 or GPAT4, because SEIPIN C-terminal truncation mutants could still co-precipitate a significant amount of GPAT3/4 ([Figure S1C](#SD1){ref-type="supplementary-material"}). Importantly, overexpressed SEIPIN immunoprecipitated endogenous GPAT3/4 (the commercial antibody recognizes both GPAT3 and GPAT4) ([Figure 2D](#F2){ref-type="fig"}). As an alternative approach, in mature adipocytes, we expressed SEIPIN that was fused to the promiscuous biotin ligase BirA\* ([@R34]). After affinity purification with streptavidin-conjugated beads, GPAT3/4 was detected only in cells expressing SEIPIN-BirA\*, but not SEIPIN or BirA\* alone ([Figure 2E](#F2){ref-type="fig"}). These data indicate that GPAT3/4 in adipocytes lies in close proximity to SEIPIN. Finally, we employed a proximity ligation assay to further examine the SEIPIN-GPAT3/4 interaction in vivo ([@R40]). GPAT3 and GPAT4 are closer to SEIPIN than AGPAT2 ([Figure S2A](#SD1){ref-type="supplementary-material"}) and, consistent with [Figure S1C](#SD1){ref-type="supplementary-material"}, full-length SEIPIN, but not its C terminus, interacted strongly with GPAT3/4 ([Figures S2B and S2C](#SD1){ref-type="supplementary-material"}). To examine the effects of SEIPIN on GPAT3/4 localization, 3T3-L1 preadipocytes were co-transfected with mCherry-SEIPIN or small hairpin RNA (shRNA) targeting SEIPIN and GFP-tagged mouse GPAT3 or GPAT4 and treated with fatty acids. GPAT3 primarily localizes to LDs, and SEIPIN overexpression or knockdown had little effect on GPAT3 localization ([Figures S3A, S3B, and S3D](#SD1){ref-type="supplementary-material"}). GPAT4 localizes to both ER and LDs, and SEIPIN knockdown increased the proportion of GPAT4 on LDs ([Figures S3C, S3E, and S3F](#SD1){ref-type="supplementary-material"}).

GPAT Activity Is Increased in SEIPIN-Deficient Cells and Tissues {#S7}
----------------------------------------------------------------

To test whether SEIPIN interacts with GPAT to regulate its activity, we measured GPAT activity in control and SEIPIN-deficient yeast cells, mammalian cells, and mouse testes. In the absence of SEIPIN, the protein expression of the microsomal GPAT isoforms was virtually unchanged ([Figures S4A--S4C](#SD1){ref-type="supplementary-material"}). However, GPAT-specific activity in *fld1 null* yeast cells was \~60% higher than in controls ([Figure 3A](#F3){ref-type="fig"}). In *Seipin*^−/−^ mouse embryonic fibroblasts (MEFs), the total and microsomal GPAT activities were twice as high as in control MEFs ([Figures 3B](#F3){ref-type="fig"} and [S4C](#SD1){ref-type="supplementary-material"}). Similarly, when *Seipin* was knocked down by \~70% in 3T3L1 preadipocytes, GPAT activity was twice as high as in control preadipocytes ([Figures 3C](#F3){ref-type="fig"}, [S4D, and S4E](#SD1){ref-type="supplementary-material"}), and in mouse testes, where *Seipin* is normally highly expressed, total, NEM-sensitive (GPAT2, 3&4) and NEM-resistant (GPAT1) GPAT activities were 67%, 75%, and 29% higher, respectively, in *Bscl2*^−/−^ testes than in controls ([Figures 3D](#F3){ref-type="fig"} and [S4F](#SD1){ref-type="supplementary-material"}). Taken together, these data demonstrate that SEIPIN downregulates GPAT activity and that this regulatory role is conserved from yeast to mammals.

SEIPIN-Deficient Cells and Tissues Had Altered GPAT Kinetics {#S8}
------------------------------------------------------------

Next, we investigated GPAT enzyme kinetics by characterizing the affinity of GPAT for its substrates, glycerol-3-phosphate (glycerol-3-P) and long-chain acyl-CoA. Because acyl-CoAs are amphipathic and may act as detergents to disrupt membranes and inhibit enzyme activity ([@R30]), the apparent K~M~ values for acyl-CoAs often cannot be accurately calculated. In the absence of SEIPIN, the affinity of GPAT for glycerol-3-P or palmitoyl-coenzyme A (palmitoyl-CoA) was altered in MEFs, 3T3L1 cells ([Figures 3E--3H](#F3){ref-type="fig"} and [S4G--S4J](#SD1){ref-type="supplementary-material"}), yeast, and *Bscl2*^−/−^ mouse testis ([Figures S4K--S4N](#SD1){ref-type="supplementary-material"}). In each case, GPAT-specific activity and V~max~ increased ([Table S2](#SD1){ref-type="supplementary-material"}).

Increased GPAT Activity Underpins the Change in LD Morphology in SEIPIN-Deficient Cells {#S9}
---------------------------------------------------------------------------------------

The above data indicate that SEIPIN interacts with GPAT to inhibit its activity. Although the immediate product of GPAT catalysis is lysophosphatidic acid, GPAT is the rate-limiting step, and the next enzyme in this synthetic pathway, lysophosphatidic acyltransferase, rapidly converts lysophosphatidic acid (LPA) to PA. Thus, increasing GPAT activity increases the level of PA in mammalian cells ([@R50], [@R52]). In yeast, elevated PA in the ER is associated with the formation of "supersized" LDs in *fld1* null cells ([@R16]), which had higher GPAT activity ([Figures 3](#F3){ref-type="fig"} and [S4G--S4J](#SD1){ref-type="supplementary-material"}). Is the increase in GPAT activity sufficient to raise the amount of PA on the ER and drive the formation of supersized LDs? Indeed, overexpressing wild-type, but not "catalytically dead," *GAT1* and *GAT2* in yeast cells caused supersized LDs to form ([Figures 4A](#F4){ref-type="fig"} and [S5A](#SD1){ref-type="supplementary-material"}), phenocopying *fld1* null cells. The level of PA in the ER was higher in these cells, similar to *fld1* null cells, as indicated by increased *INO1* expression ([Figure S5B](#SD1){ref-type="supplementary-material"}) ([@R23]). As detected by mass spectrometry, overexpression of GAT2 increased microsomal PA ([Figure 4B](#F4){ref-type="fig"}). Importantly, when either *GAT1* or *GAT2* was co-expressed with *FLD1*, the amount of PA in the ER was reduced and few supersized LDs were detected ([Figures 4A, 4B](#F4){ref-type="fig"}, and [S5B](#SD1){ref-type="supplementary-material"}). These results suggest that loss of Fld1 increases GPAT activity and the level of PA in the ER, causing the formation of supersized LDs.

Supersized LDs are also present in SEIPIN-deficient mature adipocytes and testes, tissues in which SEIPIN is normally highly expressed ([@R20]; [@R22]). Overexpressing both GPAT3 and GPAT4 in 3T3-L1 preadipocytes increased microsomal PA and formed enlarged LDs ([Figures 4C--4E](#F4){ref-type="fig"} and [S5C](#SD1){ref-type="supplementary-material"}), but as in yeast, overexpressing SEIPIN together with GPAT3 and GPAT4 reduced LD size and microsomal PA ([Figures 4C--4E](#F4){ref-type="fig"}). Moreover, knocking down *Seipin/Bscl2* in 3T3 L1 preadipocytes increased the size of LDs, a feature that was reversed by knocking down either *Gpat3* or *Gpat4* ([Figures S5D and S5E](#SD1){ref-type="supplementary-material"}). In Huh7 cells, where there is little SEIPIN expression, over-expressing GPAT3 or GPAT4 alone can dramatically increase LD size ([Figure S5F](#SD1){ref-type="supplementary-material"}). To further investigate the functional relationship between SEIPIN and GPAT at system level, we examined the morphology of the larval salivary gland of *Drosophila*. Numerous globular structures are present in *dSeipin* mutants ([Figure 5A](#F5){ref-type="fig"}) ([@R44]), and these structures can be encircled by a lipid droplet surface marker PLIN1-mCherry ([Figure 5B](#F5){ref-type="fig"}), indicating that they are lipid droplets. GPAT (*Drosophila* gene CG5508) overexpression results in large lipid droplets similar to *dSeipin* mutants ([Figure 5C](#F5){ref-type="fig"}), while overexpressing AGPAT (CG17608), Lipin (CG8709), or DGAT (CG31991) using the same promoter leads to many tiny lipid droplets. ACAT (CG8112) overexpression forms small lipid droplets and aberrant patch-like structures. Finally, knocking down SEIPIN in *Drosophila* S2 cells increased LD size, which was suppressed by knocking down GPAT simultaneously ([Figure 5D](#F5){ref-type="fig"}). Together, these results strongly suggest that increased GPAT activity underpins the formation of supersized LDs in SEIPIN-deficient cells and tissues.

During Early Differentiation, SEIPIN Alters GPAT Kinetics {#S10}
---------------------------------------------------------

In addition to its role in modulating LD expansion, SEIPIN is required for normal adipogenesis. Loss of *Seipin* disrupts adipogenesis within the first few hours of differentiation ([@R9]; [@R29]). We asked whether this feature was also related to SEIPIN's ability to regulate GPAT activity and PA metabolism. We first examined whether the level of PA is disturbed in *Seipin* knockdown 3T3-L1 preadipocytes by mass spectrometry. As shown in [Figures 6A and 6B](#F6){ref-type="fig"}, total microsomal PA and the majority of PA species were significantly increased upon SEIPIN depletion. We then examined GPAT kinetics during the differentiation of 3T3L1 preadipocytes. In wild-type (WT) cells, the apparent K~M~ values for glycerol-3-P after 0, 4, 8 and 12 hr of differentiation were 176, 267, 176, and 153 μM, respectively ([Figure S6A](#SD1){ref-type="supplementary-material"}), consistent with a transient drop in affinity for glycerol-3-P at 4 hr. In contrast, the apparent K~M~ values for glycerol-3-P in *Seipin* knockdown cells at the same time points were 113, 147, 142, and 138 μM, respectively, values considerably lower than in the control cells ([Figures S6B and S6C](#SD1){ref-type="supplementary-material"}). These findings suggest the possibility that SEIPIN regulates GPAT kinetics early during differentiation to regulate PA homeostasis.

Increased GPAT3 Activity Impairs Adipogenesis in SEIPIN-Deficient Cells {#S11}
-----------------------------------------------------------------------

If SEIPIN deficiency increases GPAT3 activity sufficiently to block adipogenesis, then reducing GPAT3 in SEIPIN-deficient cells should be able to restore adipogenesis. As predicted, in *Seipin*-deficient 3T3L1 preadipocytes, knocking down *Gpat3*, but not *Gpat4*, significantly enhanced adipocyte differentiation ([Figures 6C, 6D](#F6){ref-type="fig"}, [S6D, and S7A--S7E](#SD1){ref-type="supplementary-material"}). Finally, to determine whether the increased GPAT activity is sufficient to block adipocyte differentiation, we overexpressed *Gpat3* or *Gpat4* in 3T3L1 preadipocytes. Overexpression of *Gpat3* blocked adipogenesis ([Figures S7F--S7H](#SD1){ref-type="supplementary-material"}), whereas overexpressing *Gpat4* had only a moderate inhibitory effect on adipogenesis (data not shown). Importantly, the simultaneous overexpression of *Seipin* and *Gpat3* restored normal differentiation ([Figure S7F--S7H](#SD1){ref-type="supplementary-material"}). Taken together, these findings strongly support the interpretation that increased GPAT activity underlies the block in adipogenesis in *Seipin*-deficient cells.

GPAT Inhibitor Partially Rescues the Differentiation of Seipin^−/−^ Preadipocytes {#S12}
---------------------------------------------------------------------------------

Our results above strongly suggest that pharmacological inhibition of GPAT activity may also restore the differentiation of SEIPIN-deficient cells. Thus, we isolated primary preadipocytes from control and *Seipin*-deficient mice and differentiated them in the presence or absence of a GPAT inhibitor (formula: C21H26CINO4S) ([@R28]; [@R49]). The inhibition was competitive for NEM-sensitive (microsomal) and NEM-resistant (mitochondrial) GPAT activities ([Figure 7A](#F7){ref-type="fig"}). Inhibition of GPAT at 40 μM increased the number of cells positively stained with Oil red O, as well as the expression of adipogenesis marker genes in *Seipin*^−/−^ cells ([Figures 7B and 7C](#F7){ref-type="fig"}).

DISCUSSION {#S13}
==========

SEIPIN's role in mammalian lipid storage is unique, because it regulates both adipocyte differentiation and the expansion of cellular LDs ([@R14]). However, as an integral membrane protein of the ER without known functional domains, SEIPIN's mechanism of action has been difficult to understand. Here, we demonstrate that SEIPIN and its yeast ortholog, Fld1, can interact specifically with the ER-located GPAT isoforms and that this evolutionarily conserved interaction diminishes the specific activity of both yeast and mammalian GPAT isoforms and alters their substrate affinities. Our data provide strong evidence that when SEIPIN is absent, enhanced microsomal GPAT activity results in defective adipogenesis and altered LD morphology.

The acylation of glycerol-3-P, catalyzed by GPAT, is the initial and rate-limiting step in the synthesis of triacylglycerol and the glycerophospholipids. The mitochondrial isoform GPAT1 contributes between 20% and 50% of the total GPAT activity in liver but only \~10% of total GPAT activity in other tissue types ([@R10]). A second mitochondrial GPAT isoform, GPAT2, is expressed primarily in testes. The microsomal GPAT isoforms, GPAT3 and GPAT4, have an 80% amino acid identity and, like the two Gat isoforms in yeast, are integral membrane proteins of the ER ([@R26]) but may move to the surface of LDs during LD expansion ([@R47]). Similarly, yeast Gat1 may be present on LDs during the stationary phase of yeast growth ([@R26]). Insulin increases the activities of mammalian GPAT3 and GPAT4 by phosphorylation at Ser and Thr residues, although the functional outcome of these modifications is unclear ([@R35]). Overall, the regulation of the ER GPATs remains largely unexplored, and no GPAT-interacting proteins have previously been identified.

Through a non-biased screen in yeast, we identified the yeast GPAT, Gat1, as a potential interacting partner of the yeast SEIPIN ortholog, Fld1. Multiple lines of evidence support a specific physical association between orthologs of SEIPIN and ER GPATs. Yeast and mammalian SEIPIN were co-immunoprecipitated with their respective yeast and mammalian GPAT orthologs, and both biotinylation and proximity ligation assays confirmed the close proximity of SEIPIN and GPAT3/4. Interestingly, compared to wild-type SEIPIN, the disease-causing missense mutant T78A had a weakened association with GPAT3/4. These data strongly support a specific physical association between SEIPIN and GPAT3/4. However, because both SEIPIN and the ER GPATs are integral membrane proteins that have resisted purification, we are unable to determine their stoichiometry in vitro or whether their interaction is direct. Because SEIPIN forms oligomers ([@R39]; [@R3]; [@R15]), it is possible that a single GPAT3/4 molecule may interact with a SEIPIN oligomer. Moreover, whether SEIPIN missense mutants such as T78A cause lipodystrophies through reduced interaction with GPAT remains inconclusive, and future studies will focus on this aspect.

The specific link between orthologs of SEIPIN and the ER GPAT isoforms was strongly and consistently supported by functional assays. SEIPIN deficiency is associated with two striking phenotypes: (1) a near complete block in adipogenesis and (2) the enlargement of LDs in yeast and in those mammalian cells and tissues in which SEIPIN is normally highly expressed, such as testes and mature adipocytes ([@R22]; [@R20]). SEIPIN's association with the ER GPAT isoforms can explain its roles in adipogenesis and LD expansion. As illustrated in [Figure S8](#SD1){ref-type="supplementary-material"}, our data support the hypothesis that when SEIPIN interacts with the ER GPATs, their enzymatic activity is reduced and the production of PA is diminished. Thus, the normal interaction of SEIPIN and the ER GPAT isoforms results in two major consequences: (1) because PA inhibits PPARγ, low GPAT activity during the first few hours of adipocyte differentiation permits PPARγ to be fully active, so that normal adipogenesis can proceed; and (2) in mature adipocytes, yeast, and other cells, SEIPIN-regulated ER GPAT activity controls the size of LDs, possibly by limiting the amount of fusogenic PA ([Figure S7](#SD1){ref-type="supplementary-material"}). Conversely, in the absence of SEIPIN, ER GPAT-specific activity is enhanced and PA production increases. The high PA concentration may inhibit PPARγ activity or other signaling pathways in preadipocytes, thereby blocking adipogenesis ([@R41]; [@R51]; [@R27]). In other cells, the absence of SEIPIN also results in high GPAT activity and increased local production of PA at the ER, resulting in aberrant LD budding and growth and the formation of supersized LDs ([@R16]). Several critical experiments support this interpretation, including the altered GPAT kinetics when SEIPIN is absent, the near-normal adipocyte differentiation that occurs when both SEIPIN and GPAT3 are absent, the formation of supersized LDs when the ER GPATs are overexpressed, and the reduction in LD size when SEIPIN and GPAT are co-expressed.

SEIPIN has been reported to interact with two other glycerolipid synthetic enzymes, AGPAT2 and LIPIN1 ([@R43]; [@R38]). However, there is a fundamental difference between those studies and ours. SEIPIN was proposed to facilitate AGPAT2 and LIPIN1 function, whereas our data suggest that SEIPIN inhibits GPATs. Moreover, although the interaction of SEIPIN with AGPAT2 and LIPIN1 is relevant for the metabolism of PA, GPAT is recognized as the rate-limiting enzyme in the pathway. Importantly, the notion that SEIPIN anchors and facilitates LIPIN function overlooks existing physiological evidence ([@R43]). For example, depleting lipin-1 in mouse adipocytes reduces the size of LDs, whereas depleting Seipin in mouse adipocytes increases LD size ([@R27]; [@R22]). Furthermore, our co-immunoprecipitation study in yeast could not detect a SEIPIN-LIPIN1 interaction (data not shown), and the yeast AGPAT2 homolog, Slc4, did not co-precipitate well with Fld1. Importantly, when overexpressed in the salivary gland of *Drosophila* under the same promoter, GPAT is the only enzyme that gave rise to supersized LDs.

In *Drosophila*, SEIPIN has been reported to interact with sarco/endoplasmic reticulum calcium ATPase (SERCA), an ER-specific calcium pump ([@R2]). However, alterations in ER fatty acid and lipid composition are known to inhibit SERCA activity ([@R17]). Because our results support a primary function of SEIPIN in ER phospholipid metabolism, the disrupted calcium homeostasis observed in SEIPIN-deficient cells may be secondary to an altered ER phospholipid composition. Recent data also suggest that SEIPIN is involved in the vectorial export of TAG from the ER or the stabilization of ER-LD contact sites ([@R7]; [@R18]). Our findings described here do not necessarily contradict with those observations; changes in PA concentration/localization of the ER may also impact the vectorial budding of droplets and/or the phospholipid composition of LDs ([@R48]; [@R19]).

Although both GPAT3 and GPAT4 can interact with SEIPIN, they exhibited clear functional differences. Overexpressing either enzyme altered LD morphology at least in Huh7 cells, but only GPAT3 appeared to play a major role in adipogenesis ([@R35]). Surprisingly, although GPAT3 is highly upregulated in differentiating adipocytes, *Gpat3*^−/−^ mice had relatively modest phenotypic alterations, and decreased weight gain was detected only when *Gpat3*^−/−^ mice were fed a high-fat diet ([@R5]). GPAT4 is moderately upregulated during adipogenesis, but it is the major microsomal GPAT activity in brown adipose tissue, where its presence is required to limit the oxidation of exogenous fatty acids ([@R11]). Murine GPAT4 is known to localize to LDs ([@R47]); however, our data suggest that both ER GPATs can localize to LDs, particularly GPAT3.

Taken as a whole, our data provide strong evidence that SEIPIN interacts with and regulates ER GPATs in mammalian cells, fly, and *S. cerevisiae*. This is the first example of an evolutionarily conserved, physiological regulator of the ER GPATs.

EXPERIMENTAL PROCEDURES {#S14}
=======================

Materials {#S15}
---------

Strains, primers, plasmids, and antibodies are listed in [Tables S3--S7](#SD1){ref-type="supplementary-material"}. \[^3^H\] Glycerol-3-P was synthesized enzymatically ([@R8]).

Isolation of Fld1-Interacting Proteins {#S16}
--------------------------------------

Wild-type yeast cells transformed with plasmid pLacYCP-GFP and *fld1Δ* cells transformed with pLacYCP-Fld1-GFP were grown to early stationary phase and then lysed using a bead beater in three different buffers: buffer 1 (25 mM Tris-HCl \[pH 8.0\], 150 mM NaCl, 0.5% Triton X-100, 0.2 mM EDTA, and 0.2 mM DTT), buffer 2 (20 mM K-HEPES \[pH 7.4\], 110 mM CH~3~CO~2~K, 150 mM NaCl, 0.1% Triton X-100, 0.1% Tween 20, and 2 mM MgCl~2~), and buffer 3 (20 mM K-HEPES \[pH 7.4\], 110 mM CH~3~CO~2~K, 150 mM NaCl, 0.1% Triton X-100, 0.1% Tween 20, 46 mM n-octyl-B-D-glucopyranoside, 2 mM MgCl~2~, and 5% glycerol). Cell lysates were initially incubated with Sepharose CL-4B (GE Healthcare) to pull down proteins interacting with beads, and the supernatants were affinity purified using a GFP-Trap (ChromoTek) ([@R33]) to pull down proteins interacting with GFP and Fld1-GFP, respectively.

Identification of Fld1-Interacting Candidates {#S17}
---------------------------------------------

Proteins were eluted from Sepharose and GFP-Trap beads with a low-pH buffer (pH 2) containing 100 mM glycine, neutralized, and separated on 4%--15% Tris-HCl gels (Bio-Rad). After staining with Coomassie brilliant blue R-250 (Sigma), protein bands were digested in-gel with trypsin ([@R37]), and the sequences of the resultant peptides were determined by liquid chromatography tandem mass spectrometry using LTQ-Orbi-trap Velos Pro (Thermo Fisher Scientific) coupled to UltiMate 3000 RSLC (Dionex). A list of candidate interactors was created from proteins identified in at least three Fld1-GFP pull-downs and absent in the controls ([Table S1](#SD1){ref-type="supplementary-material"}). Proteins were identified by at least two unique unmodified peptides with a score of −20.

Yeast Growth {#S18}
------------

Yeast cells were grown as described previously ([@R36]).

Mammalian Cell Culture {#S19}
----------------------

HeLa, MEF, 3T3-L1, HEK293FT, and Phoenix Eco cells were grown in DMEM, 10% fetal bovine serum (FBS) (Invitrogen), and 100 U/mL penicillin and streptomycin. Cells were transiently transfected with plasmids using Lipofectamine LTX/Plus (Invitrogen). To induce triacylglycerol synthesis and LD formation, cells were incubated for 16 hr with 400 or 800 μM BSA-coupled oleate.

Retro- and Lentivirus Production and Stable Cell Line Generation {#S20}
----------------------------------------------------------------

pLKO.1-based shRNA lentiviral or pBABE-based retroviral expression constructs ([Table S6](#SD1){ref-type="supplementary-material"}) were used to generate lentivirus in HEK293T cells or retro-virus in Phoenix Eco cells, respectively. 3T3-L1 cells were incubated for 24 hr with lenti- or retrovirus together with 8 μg/mL polybrene. Stable cells were selected with 4 μg/mL puromycin and/or 800 μg/mL neomycin for 10 days before use or storage in liquid N~2~.

Adipocyte culture and differentiation and qRT-PCR were carried out as described previously ([@R9]; [@R29]).

Pre-adipocyte Isolation and Differentiation {#S21}
-------------------------------------------

Animal protocols were approved by the University of North Carolina at Chapel Hill Institutional Animal Care and Use Committee. Mouse preadipocytes were isolated from gonadal adipose tissue. After excising blood vessels, adipose tissue was minced into small pieces, decanted into isolation medium (DMEM supplemented with 25 mM HEPES, 2% BSA, and 2 mg/mL collage-nase), and digested for 30 min at 37°C with constant shaking. Suspended cells were then filtered through a 100-μm nylon filter, centrifuged for 5 min at 400 × *g*, and resuspended in DMEM supplemented with 10% newborn calf serum and 100 U/mL penicillin and streptomycin. Differentiation was carried out as described above, and the GPAT inhibitor was present during the first 48 hr of differentiation.

GPAT Activity and Kinetics {#S22}
--------------------------

The right testis or MEFs and 3T3L1 cells from 10-cm dishes were homogenized in cold medium I (250 mM sucrose, 10 mM Tris \[pH 7.4\], 1 mM EDTA, 1 mM DTT) using 10 up-and-down strokes with a Teflon-glass motor-driven homogenizer. Total membranes were isolated by centrifuging the homogenate at 100,000 × *g* for 1 hr. GPAT specific activity (initial rates) was assayed for 10 min at room temperature (RT) in a 200 μL reaction mixture containing 75 mM Tris-HCl (pH 7.5), 4 mM MgCl~2~, 1 mg/mL BSA (essentially fatty-acid-free), 1 mM DTT, 8 mM NaF, 800 μM \[^3^H\]glycerol-3-P, and 82.5 μM palmitoyl-CoA. Membrane protein was incubated on ice for 15 min in the presence or absence of 2 mM NEM, which inactivates GPAT isoforms 2, 3, and 4 ([@R21]). The reaction was initiated by adding 20 μg (testis), 15 μg (MEFs), or 5 μg (3T3L1) of membrane protein. Reaction products were extracted into 2 mL CHCl~3~. NEM-resistant activity (GPAT1) was calculated by subtracting NEM-sensitive activity from total activity. To determine the reaction products, 1 mL of the CHCl~3~ extract was dried under N~2~, resuspended in 30 μL CHCl~3~:CH~3~OH (2:1; v/v), and separated by thin-layer chromatography (CHCl~3~:pyridine:88% formic acid, 50:30:7; v/v). More than 90% of the reaction product was PA, and the remainder was lysophosphatidic acid. \[^3^H\]Glycerol-3-P concentrations (40--400 μM) or palmitoyl-CoA concentrations (11.25--150 μM) were varied to analyze enzyme kinetics.

BY4741 and *fld1*Δ cells were collected by centrifuging at 3,000 × *g* for 5 min, rinsed twice in dH~2~O, and stored at −80°C until further use. To obtain total membrane fractions, yeast cells were resuspended in 1 mL zymolyase buffer (50 mM potassium phosphate \[pH 7.5\], 10 mM β-mercaptoethanol) containing 1,000 U zymolyase (Zymo Research). Cell suspensions were shaken at 150 rpm at 30°C for 90 min. The supernatant was then homogenized, and membranes were isolated by centrifugation as described above. To assay GPAT activity in yeast, 20 μg membrane protein was pre-incubated in the presence of 50 μM 16:0 CoA for 1 hr. Reactions were initiated by adding the \[^3^H\] glycerol-3-phosphate. To analyze enzyme kinetics in yeast, \[^3^H\] glycerol-3-P concentrations (5--400 μM) or palmitoyl-CoA concentrations (12.5--100 μM) were varied.

Co-immunoprecipitation and Western Blotting {#S23}
-------------------------------------------

Antibodies used are listed in [Table S8](#SD1){ref-type="supplementary-material"}. Yeast cell lysates were prepared as described previously ([@R13]). 2 mg protein was used for each co-immunoprecipitation condition. Antibody was immobilized on magnetic Dynabeads (Dynabeads Co-Immunoprecipitation Kit manual). After 30 min of incubation with the cell lysates containing overexpressed protein at RT, or after overnight incubation with the cell lysates containing low levels of recombinant protein at 4°C, beads were washed and eluted at 37°C for 20 min. Proteins were transferred onto polyvinylidene fluoride (PVDF) membranes, followed by immunodetection ([@R13]).

Transiently or stably transfected mammalian cells (MEFs, mouse 3T3-L1preadipocytes, and HeLa cells) were washed three times with ice-cold PBS and lysed in immunoprecipitation (IP) lysis/wash buffer (as above) containing 1% (w/v) n-dodecyl-β-D-maltopyranoside (DDM; Sigma) by forcing the cells 30 times through a 0.8-mm needle. Immunoprecipitation and western blotting were carried out as described above.

BirA\* Pull-Down Assays {#S24}
-----------------------

The cDNA for BirA\* was subcloned from pGEM-SD2-BirA\* (a kind gift of John Strouboulis, Erasmus University Medical Center, Rotterdam, the Netherlands). 3T3-L1 preadipocytes were transduced with FLAG-tagged SEIPIN, FLAG-tagged biotin ligase BirA\*, or FLAG-tagged BirA\*-SEIPIN delivered using retrovirus, and cells were then induced to differentiate to mature adipocytes. On day 8 of differentiation, cells were treated with 50 μM biotin for 24 hr and then lysed. Cell lysates were precleared with empty protein G agarose beads for 4 hr and then incubated with streptavidin-conjugated agarose for 2 hr at room temperature. The beads were collected and washed with buffers as described previously ([@R34]), incubated with sample buffer containing 1.5 mM biotin, and heated for 1 hr at 65°C before western blot analysis.

Proximity Ligation Assay {#S25}
------------------------

HeLa cells transfected with indicated plasmids were fixed with 4% paraformaldehyde (Electron Microscopy Sciences) for 15 min and permeabilized with 0.2% Triton X-100 (Sigma-Aldrich) for 10 min at room temperature. Cells were then blocked with 3% BSA in PBS for 1 hr and incubated with appropriate combinations of mouse anti-FLAG (1:100; Clontech Laboratories) and rabbit anti-HA (1:3,000; CST) antibodies diluted in blocking solution for 1 hr at room temperature. This was followed by proximity ligation assay using the Du-olink detection reagent kit (Olink Bioscience) according to the manufacturer's protocol. Fluorescence images were acquired using an Olympus Fluoview FV1200 confocal microscope with a 60×/1.35 UPlanSApo objective. Images were prepared and analyzed with Fiji software (<http://fiji.sc>). For each experiment, signals from at least 50 cells were quantified. All data were analyzed using GraphPad PRISM software.

Fluorescence Microscopy {#S26}
-----------------------

Yeast cells were stained with 20 μg/mL Nile red (Sigma-Aldrich). For mammalian lipid droplets, BODIPY 493/503 (Invitrogen) was used. Imaging was performed using a Leica SP5 confocal microscope and a Leica HCX 63× 1.4 numerical aperture objective.

Lipidomic Analysis of Microsomal PA {#S27}
-----------------------------------

Phospholipids were extracted from microsomes isolated from yeast or mammalian cells, subjected to high performance liquid chromatography (HPLC) tandem mass spectrometry (MS/MS) and analyzed using Lipid Search software as described ([@R32]; [@R16]).

*Drosophila* experiments are as described previously ([@R44]). *ppl-Gal4* was used to drive the overexpression of genes indicated.

Statistics {#S28}
----------

Experiments were performed in triplicate. The results are presented as mean ± SD. Two-tailed Student's t test was used for comparison.

Supplementary Material {#S30}
======================

Mass spectrometric analysis was performed at the Bioanalytical Mass Spectrometry Facility, University of New South Wales and supported in part by infrastructure funding from the New South Wales Government. H.Y. was supported by grants 1057852 and 1078117 from the National Health and Medical Research Council, Australia, and by grants DP130100457 and DP120101543 from the Australian Research Council. H.Y. is a Senior Research Fellow of the NHMRC. R.A.C. was supported by NIH grant DK56598.
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![Fld1, Ldb16, and Gat1/2 Interact in Yeast\
(A) Co-immunoprecipitation assay detecting the interaction between overexpressed Gat1-V5 and Fld1-FLAG in yeast lysates.\
(B) Gat1-V5 and Ldb16 of endogenous level co-immunoprecipitate with Fld1-FLAG.\
(C) Using V5 antibody, overexpressed Fld1-FLAG co-immunoprecipitates with overexpressed Gat1-V5 and Gat2-V5 from wild-type and *ldb16Δ* yeast lysates.\
See also [Figure S1](#SD1){ref-type="supplementary-material"} and [Table S1](#SD1){ref-type="supplementary-material"}.](nihms907566f1){#F1}

![Mammalian SEIPIN and GPAT3/4 Physically Interact\
(A) Co-immunoprecipitation by FLAG and hemagglutinin (HA) antibody of overexpressed FLAG-tagged GPAT3 or GPAT4 and HA-tagged SEIPIN, respectively, from transfected MEF cell lysates.\
(B and C) Immunoblotting for overexpressed HA-tagged mutant or wild-type SEIPIN and FLAG-tagged GPAT3 and GPAT4, respectively, after HA-immunoprecipitation from 3T3-L1 cells. See also [Figure S2](#SD1){ref-type="supplementary-material"}.\
(D) Endogenous GPAT4 and GPAT3 proteins co-immunoprecipitate with overexpressed SEIPIN from 3T3-L1 adipocytes stably transfected with HA- or FLAG-SEIPIN.\
(E) 3T3-L1 adipocytes expressing FLAG-SEIPIN, FLAG-tagged biotin ligase BirA\*, or FLAG-tagged BirA\*-SEIPIN were treated with 50 μM biotin for 24 hr. The biotinylated proteins were pulled down using streptavidin-conjugated agarose from biological duplicates. Elutes were subjected to western blot analysis. All experiments were performed in triplicate.](nihms907566f2){#F2}

![GPAT Activity Is Significantly Increased and GPAT Kinetics Are Altered in SEIPIN-Deficient Cells and Tissues\
(A--D) GPAT specific activity (initial rates) was measured in total membrane preparations from (A) BY4741 and *fld1*Δ yeast, (B) control and *Bscl2*^−/−^ mouse embryonic fibroblasts, (C) control and *shBSCL2* 3T3L1 preadipocytes, and (D) control and *Bscl2*^−/−^ testes. Membrane proteins were incubated on ice for 15 min in the presence or absence of 2 mM NEM. Experiments were performed in triplicate. Data are presented as mean ± SEM. See also [Figure S3](#SD1){ref-type="supplementary-material"}.\
(E--H) GPAT dependence on glycerol-3-phosphate or Palmitoyl-CoA in control and *Bscl2*^−/−^ testis (E and F) and control and *shBSCL2* 3T3-L1 preadipocytes (G and H). Glycerol-3-phosphate and palmitoyl-CoA concentrations were varied as indicated. Double-reciprocal plots are shown in [Figures S3G--S3J](#SD1){ref-type="supplementary-material"}. All experiments were performed in triplicate. Data are presented as mean ± SEM.](nihms907566f3){#F3}

![Increased GPAT Activity Underpins the Change in LD Morphology in SEIPIN-Deficient Cells\
(A) Nile-red-stained lipid droplets of BY4741 wild-type (WT), *fld1*Δ, *GAT1*-, or *GAT2*-overexpressing strains (O/E Gat1 and O/E Gat2), strains over-expressing catalytically dead *gat* mutants (O/E Gat1 G262D and O/E Gat2 G253L), and double-transformed strains (O/E Gat1 + O/E Fld1 and O/E Gat2 + Fld1). The cells were grown to early stationary phase.\
(B and E) Lipidomic analysis of microsomal PA in the indicated yeast strains and transduced pre-adipocytes. Phospholipids were extracted from cells, subjected to HPLC MS/MS, and analyzed using Lipid Search software. n = 4. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001.\
(C) BODIPY-stained lipid droplets in 3T3-L1 preadipocytes, transduced with indicated lentiviral expression vectors and incubated with 400 μM oleate for 16 hr. Representative confocal images are shown.\
(D) Diameters of top three largest lipid droplets in 100 of each cell line were measured to determine the droplet volumes. Data represent mean ± SD (\*\*\*\*p \< 0.0001).\
See also [Figure S4](#SD1){ref-type="supplementary-material"}.](nihms907566f4){#F4}

![SEIPIN and GPAT Functionally Interact in *Drosophila*\
(A--C) GPAT overexpression results in large lipid droplets similar to *dSeipin* mutants in the salivary gland of *Drosophila*. (A) Differential interference contrast (DIC) image of wild-type and *dSeipin* mutant larval salivary gland. Scale bar, 100 μm. (B) The largest lipid droplets in dSeipin mutants can be encircled by lipid droplet surface marker PLIN1-mCherry. The genotype is *dSeipin; ppl-Gal4\>UAS-PLIN1-mCherry*. Scale bar, 50 μm. (C) DIC images of third-instar larval salivary gland of different genotypes. GPAT (*Drosophila* gene CG5508), AGPAT (CG17608), Lipin (CG8709), DGAT (CG31991), and ACAT (CG8112) were each overexpressed using the ppl-Gal4 promoter. Scale bar, 50 μm.\
(D) RNAi-mediated knockdown of SEIPIN in *Drosophil*a S2 cells increases LD size, which can be suppressed by simultaneously knocking down GPAT. Representative confocal images of RNAi-treated and BODIPY-stained cells are shown. Scale bar, 10 μm. Statistical testing utilized one-way ANOVA with a post-Tukey's multiple comparison test. Error bars represent ± SEM. \*\*\*p \< 0.001.](nihms907566f5){#F5}

![Increased GPAT3 Activity Impairs Adipogenesis in SEIPIN-Deficient Preadipocytes\
(A and B) Lipidomic analysis of microsomal PA in control and s*hBSCL2* 3T3L1 preadipocytes. Phospholipids were extracted from cells, subjected to HPLC MS/MS, and analyzed using Lipid Search software. n = 4. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001.\
(C) Oil red O stains of differentiated/undifferentiated 3T3-L1 cells stably transfected with the indicated lentiviral knockdown vectors.\
(D) *Pparγ*, *aP2* and *C/ebpα* mRNA levels were measured by qRT-PCR in 3T3-L1 cells transduced with the indicated lentiviral knockdown vectors at the indicated time points after induction of differentiation. All experiments were performed in triplicate. See also [Figure S5](#SD1){ref-type="supplementary-material"}.](nihms907566f6){#F6}

![GPAT Inhibitor Can Partially Rescue the Differentiation of *Seipin*^−/−^ Preadipocytes\
(A) Glycerol-3-phosphate dependence of GPAT was determined by incubating 10--20 μg total particulate in the presence of 82.5 μM 16:0 CoA and varying the concentration of G3P from 10 to 800 μM, in the absence or presence of NEM. All experiments were performed in triplicates. Data are presented as mean ± SEM. See also [Figure S6](#SD1){ref-type="supplementary-material"}.\
(B) The recovery of differentiation (day 8) is shown by Oil red O staining of WT, *Bscl2* KO, and *Bscl2* KO MEF cells treated with 40 μM inhibitor during the first 2 days of differentiation.\
(C) Total RNA extracted from wild-type and *Seipin*^−/−^ preadipocytes cultured in the presence or absence of GPAT inhibitor was used to measure the indicated mRNA levels by qPCR. Values represent mean ± SD of three independent experiments performed in triplicate. Statistical analysis was performed using Student's t test. \*p \< 0.05, inhibitor treatment versus DMSO in *Seipin* KO cells.](nihms907566f7){#F7}

###### Highlights

-   Loss of SEIPIN function causes Berardinelli-Seip congenital lipodystrophy 2

-   Lack of SEIPIN increases glycerol-3-phosphate acyltransferase (GPAT) activity

-   Inhibiting GPAT enhances differentiation of SEIPIN-deficient preadipocytes

-   Inhibiting GPAT corrects abnormal lipid droplet morphology in SEIPIN deficiency

[^1]: Co-first author

[^2]: Present address: Institute for Future Environments, Queensland University of Technology, Brisbane, QLD 4000, Australia

[^3]: Lead Contact
